Tengjun Biotechnology Corp. Proceeds from Contributed Capital
Tengjun Biotechnology Corp. reported Proceeds from Contributed Capital of $300.00 thousand for the 9-month period ending 2022-09-30, per its 10-Q filed 2022-11-14.
Discontinued › Cash Flow › Financing Activities
us-gaap:ProceedsFromContributedCapital · last filed 2023-04-17
- Tengjun Biotechnology Corp. proceeds from contributed capital for fiscal 2021 was $7.75K.
| Period end | Proceeds from Contributed Capital 9 month | Proceeds from Contributed Capital 12 month |
|---|---|---|
| 2022-09-30 | $300.00K 10-Q · filed 2022-11-14 | |
| 2021-12-31 | $7.75K 10-K · filed 2023-04-17 |